129 related articles for article (PubMed ID: 16289064)
1. Protection against soman or VX poisoning by human butyrylcholinesterase in guinea pigs and cynomolgus monkeys.
Lenz DE; Maxwell DM; Koplovitz I; Clark CR; Capacio BR; Cerasoli DM; Federko JM; Luo C; Saxena A; Doctor BP; Olson C
Chem Biol Interact; 2005 Dec; 157-158():205-10. PubMed ID: 16289064
[TBL] [Abstract][Full Text] [Related]
2. Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review.
Lenz DE; Yeung D; Smith JR; Sweeney RE; Lumley LA; Cerasoli DM
Toxicology; 2007 Apr; 233(1-3):31-9. PubMed ID: 17188793
[TBL] [Abstract][Full Text] [Related]
3. Post-exposure therapy with human butyrylcholinesterase following percutaneous VX challenge in guinea pigs.
Mumford H; E Price M; Lenz DE; Cerasoli DM
Clin Toxicol (Phila); 2011 Apr; 49(4):287-97. PubMed ID: 21563904
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and physiological effects of human butyrylcholinesterase as a post-exposure therapy against percutaneous poisoning by VX in the guinea-pig.
Mumford H; Price ME; Cerasoli DM; Teschner W; Ehrlich H; Schwarz HP; Lenz DE
Chem Biol Interact; 2010 Sep; 187(1-3):304-8. PubMed ID: 20176007
[TBL] [Abstract][Full Text] [Related]
5. Butyrylcholinesterase as a therapeutic drug for protection against percutaneous VX.
Lenz DE; Clarkson ED; Schulz SM; Cerasoli DM
Chem Biol Interact; 2010 Sep; 187(1-3):249-52. PubMed ID: 20513442
[TBL] [Abstract][Full Text] [Related]
6. Prophylaxis with human serum butyrylcholinesterase protects guinea pigs exposed to multiple lethal doses of soman or VX.
Saxena A; Sun W; Fedorko JM; Koplovitz I; Doctor BP
Biochem Pharmacol; 2011 Jan; 81(1):164-9. PubMed ID: 20846507
[TBL] [Abstract][Full Text] [Related]
7. Human plasma-derived BuChE as a stoichiometric bioscavenger for treatment of nerve agent poisoning.
Mumford H; Docx CJ; Price ME; Green AC; Tattersall JE; Armstrong SJ
Chem Biol Interact; 2013 Mar; 203(1):160-6. PubMed ID: 22981459
[TBL] [Abstract][Full Text] [Related]
8. Human plasma-derived butyrylcholinesterase is behaviorally safe and effective in cynomolgus macaques (Macaca fascicularis) challenged with soman.
Myers TM
Chem Biol Interact; 2019 Aug; 308():170-178. PubMed ID: 31129133
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo characterization of recombinant human butyrylcholinesterase (Protexia) as a potential nerve agent bioscavenger.
Cerasoli DM; Griffiths EM; Doctor BP; Saxena A; Fedorko JM; Greig NH; Yu QS; Huang Y; Wilgus H; Karatzas CN; Koplovitz I; Lenz DE
Chem Biol Interact; 2005 Dec; 157-158():363-5. PubMed ID: 16429486
[TBL] [Abstract][Full Text] [Related]
10. Butyrylcholinesterase, a stereospecific in vivo bioscavenger against nerve agent intoxication.
Cerasoli DM; Armstrong SJ; Reeves TE; Hodgins SM; Kasten SA; Lee-Stubbs RB; Cadieux CL; Otto TC; Capacio BR; Lenz DE
Biochem Pharmacol; 2020 Jan; 171():113670. PubMed ID: 31628910
[TBL] [Abstract][Full Text] [Related]
11. Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates.
Broomfield CA; Maxwell DM; Solana RP; Castro CA; Finger AV; Lenz DE
J Pharmacol Exp Ther; 1991 Nov; 259(2):633-8. PubMed ID: 1941611
[TBL] [Abstract][Full Text] [Related]
12. Comparison of polyethylene glycol-conjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds.
Cohen O; Kronman C; Raveh L; Mazor O; Ordentlich A; Shafferman A
Mol Pharmacol; 2006 Sep; 70(3):1121-31. PubMed ID: 16801396
[TBL] [Abstract][Full Text] [Related]
13. The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase.
Raveh L; Grauer E; Grunwald J; Cohen E; Ashani Y
Toxicol Appl Pharmacol; 1997 Jul; 145(1):43-53. PubMed ID: 9221822
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase.
Allon N; Raveh L; Gilat E; Cohen E; Grunwald J; Ashani Y
Toxicol Sci; 1998 Jun; 43(2):121-8. PubMed ID: 9710953
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of human butyrylcholinesterase pretreatment followed by acute soman challenge in cynomolgus monkeys.
Sun W; Doctor BP; Lenz DE; Saxena A
Chem Biol Interact; 2008 Sep; 175(1-3):428-30. PubMed ID: 18674756
[TBL] [Abstract][Full Text] [Related]
16. Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. In vitro and in vivo quantitative characterization.
Raveh L; Grunwald J; Marcus D; Papier Y; Cohen E; Ashani Y
Biochem Pharmacol; 1993 Jun; 45(12):2465-74. PubMed ID: 8328984
[TBL] [Abstract][Full Text] [Related]
17. Estimation of the upper limit of human butyrylcholinesterase dose required for protection against organophosphates toxicity: a mathematically based toxicokinetic model.
Ashani Y; Pistinner S
Toxicol Sci; 2004 Feb; 77(2):358-67. PubMed ID: 14600276
[TBL] [Abstract][Full Text] [Related]
18. Bioscavenger is effective as a delayed therapeutic intervention following percutaneous VX poisoning in the guinea-pig.
Mann TM; Price ME; Whitmore CL; Perrott RL; Laws TR; McColm RR; Emery ER; Tattersall JEH; Green AC; Rice H
Toxicol Lett; 2018 Sep; 293():198-206. PubMed ID: 29183815
[TBL] [Abstract][Full Text] [Related]
19. Human serum butyrylcholinesterase: in vitro and in vivo stability, pharmacokinetics, and safety in mice.
Saxena A; Sun W; Luo C; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():199-203. PubMed ID: 16263104
[TBL] [Abstract][Full Text] [Related]
20. Post-exposure therapy with recombinant human BuChE following percutaneous VX challenge in guinea-pigs.
Mumford H; Troyer JK
Toxicol Lett; 2011 Sep; 206(1):29-34. PubMed ID: 21620937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
